Ideal candidates are individuals who: Struggle to lose weight despite efforts with diet and exercise
A study on 6,681 people using GLP-1s found that sustained GLP-1 use was associated with a 2.5% absolute risk reduction of myocardial infarction, stroke and cardiovascular mortality over 3.5 years
Federal anti-kickback regulations prohibit pharmaceutical manufacturers from offering copay assistance to patients with government insurance, including Medicare Part D, Medicaid, TRICARE, and VA benefits
"Deregulated inflammasome signaling in disease"
GraphPad software (version 9.0) was used to perform statistical analysis
Compounded semaglutide from licensed 503A pharmacies uses the same active ingredient as brand Ozempic, delivering equivalent therapeutic effects